CDKN2A Depletion Causes Aneuploidy and Enhances Cell Proliferation in Non-Immortalized Normal Human Cells

Reference

• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144:646–674. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Loeb LA, Loeb KR, Anderson JP. Multiple mutations and cancer. Proc Natl Acad Sci USA. 2003;100:776–781. doi:10.1073/pnas.0334858100
   PubMed Web of Science ®Google Scholar
• Duesberg P, Rasnick D, Li R, Winters L, Rausch C, Hehlmann R. How aneuploidy may cause cancer and genetic instability. Anticancer Res. 1999;19:4887–4906.
   PubMed Web of Science ®Google Scholar
• Zimonjic D, Brooks MW, Popescu N, Weinberg RA, Hahn WC. Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res. 2001;61:8838–8844.
   PubMed Web of Science ®Google Scholar
• Cassier PA, Ducimetière F, Lurkin A, Ranchère-Vince D, Scoazec JY, Bringuier PP, et al. A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Apes region: incidence and molecular distribution of GIST in a European region. Br J Cancer. 2010;103:165–170. doi:10.1038/sj.bjc.6605743
   PubMed Web of Science ®Google Scholar
• Andersson J, Sjögren H, Meis-Kindblom JM, Stenman G, Aman P, Kindblom LG. The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors. Am J Pathol. 2002;160:15–22. doi:10.1016/S0002-9440(10)64343-X
   PubMed Web of Science ®Google Scholar
• Astolfi A, Nannini M, Pantaleo MA, Di Battista M, Heinrich MC, Santini D, et al. A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. Lab Invest. 2010;90:1285–1294. doi:10.1038/labinvest.2010.110
   PubMed Web of Science ®Google Scholar
• Belinsky MG, Skorobogatko YV, Rink L, Pei J, Cai KQ, Vanderveer LA, et al. High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors. Genes Chromosomes Cancer. 2009;48:886–896. doi:10.1002/gcc.20689
   PubMed Web of Science ®Google Scholar
• Breiner JA, Meis-Kindblom J, Kindblom LG, McComb E, Liu J, Nelson M, et al. Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors). Cancer Genet Cytogenet. 2000;120:111–116. doi:10.1016/S0165-4608(00)00212-0
   PubMed Web of Science ®Google Scholar
• Chen Y, Liou CP, Tseng HH, Jan YJ, Li CF, Tzeng CC. Deletions of chromosome 1p and 15q are associated with aggressiveness of gastrointestinal stromal tumors. J Formos Med Assoc. 2009;108:28–37. doi:10.1016/S0929-6646(09)60029-2
   PubMed Web of Science ®Google Scholar
• Derré J, Lagacé R, Terrier P, Sastre X, Aurias A. Consistent DNA losses on the short arm of chromosome 1 in a series of malignant gastrointestinal stromal tumors. Cancer Genet Cytogenet. 2001;127:30–33. doi:10.1016/S0165-4608(00)00409-X
   PubMedGoogle Scholar
• El-Rifai W, Sarlomo-Rikala M, Miettinen M, Knuutila S, Andersson LC. DNA copy number losses in chromosome 14: an early change in gastrointestinal stromal tumors. Cancer Res. 1996;56:3230–3233.
   PubMed Web of Science ®Google Scholar
• El-Rifai W, Sarlomo-Rikala M, Andersson LC, Knuutila S, Miettinen M. DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res. 2000;60:3899–3903.
   PubMed Web of Science ®Google Scholar
• Gunawan B, Bergmann F, Höer J, Langer C, Schumpelick V, Becker H, et al. Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors. Hum Pathol. 2002;33:316–321. doi:10.1053/hupa.2002.32216
   PubMed Web of Science ®Google Scholar
• Gunawan B, Schulten HJ, von Heydebreck A, Schmidt B, Enders C, Höer J, et al. Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumours. J Pathol. 2004;202:421–429. doi:10.1002/path.1537
   PubMed Web of Science ®Google Scholar
• Lourenço N, Hélias-Rodzewicz Z, Bachet JB, Brahimi-Adouane S, Jardin F, Tran van Nhieu J, et al. Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors. Mol Cancer. 2014;13:246. doi:10.1186/1476-4598-13-246
   PubMed Web of Science ®Google Scholar
• Medeiros F, Corless CL, Duensing A, Hornick JL, Oliveira AM, Heinrich MC, et al. KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol. 2004;28:889–894. doi:10.1097/00000478-200407000-00007
   PubMed Web of Science ®Google Scholar
• Rodriguez AM, Elabd C, Delteil F, Astier J, Vernochet C, Saint-Marc P, et al. Adipocyte differentiation of multipotent cells established from human adipose tissue. Biochem Biophys Res Commun. 2004;315:255–263. doi:10.1016/j.bbrc.2004.01.053
   PubMed Web of Science ®Google Scholar
• Zaragosi LE, Ailhaud G, Dani C. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells. 2006;24:2412–2419. doi:10.1634/stemcells.2006-0006
   PubMed Web of Science ®Google Scholar
• De Preter K, Speleman F, Combaret V, Lunec J, Laureys G, Eussen BH, et al. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod Pathol. 2002;15:159–166. doi:10.1038/modpathol.3880508
   PubMed Web of Science ®Google Scholar
• Hélias-Rodzewicz Z, Pérot G, Chibon F, Ferreira C, Lagarde P, Terrier P, et al. YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas. Genes Chromosomes Cancer. 2010;49:1161–1171. doi:10.1002/gcc.20825
   PubMed Web of Science ®Google Scholar
• Wozniak A, Sciot R, Guillou L, Pauwels P, Wasag B, Stul M, et al. Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status. Genes Chromosomes Cancer. 2007;46:261–276. doi:10.1002/gcc.20408
   PubMed Web of Science ®Google Scholar
• Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell. 2003;3:421–429. doi:10.1016/S1535-6108(03)00110-7
   PubMed Web of Science ®Google Scholar
• Antoni L, Sodha N, Collins I, Garrett MD. CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin. Nat Rev Cancer. 2007;7:925–936. doi:10.1038/nrc2251
   PubMed Web of Science ®Google Scholar
• Sampath SC, Ohi R, Leismann O, Salic A, Pozniakovski A, Funabiki H. The chromosomal passenger complex is required for chromatin-induced microtubule stabilization and spindle assembly. Cell. 2004;118:187–202. doi:10.1016/j.cell.2004.06.026
   PubMed Web of Science ®Google Scholar
• Amato A, Lentini L, Schillaci T, Iovino F, Di Leonardo A. RNAi mediated acute depletion of retinoblastoma protein (pRb) promotes aneuploidy in human primary cells via micronuclei formation. BMC Cell Biol. 2009;10:79. doi:10.1186/1471-2121-10-79
   PubMed Web of Science ®Google Scholar
• Schwab RA, Blackford AN, Niedzwiedz W. ATR activation and replication fork restart are defective in FANCM-deficient cells. EMBO J. 2010;29:806–818. doi:10.1038/emboj.2009.385
   PubMed Web of Science ®Google Scholar
• El Ghamrasni S, Pamidi A, Halaby MJ, Bohgaki M, Cardoso R, Li L, et al. Inactivation of chk2 and mus81 leads to impaired lymphocytes development, reduced genomic instability, and suppression of cancer. PLoS Genet. 2011;7:e1001385. doi:10.1371/journal.pgen.1001385
   PubMed Web of Science ®Google Scholar
• McDermott KM, Zhang J, Holst CR, Kozakiewicz BK, Singla V, Tlsty TD. p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol. 2006;4:e51. doi:10.1371/journal.pbio.0040051
   PubMed Web of Science ®Google Scholar
• Stolz A, Ertych N, Kienitz A, Vogel C, Schneider V, Fritz B, et al. The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells. Nat Cell Biol. 2010;12:492–499. doi:10.1038/ncb2051
   PubMed Web of Science ®Google Scholar
• Ward IM, Minn K, van Deursen J, Chen J. p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol Cell Biol. 2003;23:2556–2563. doi:10.1128/MCB.23.7.2556-2563.2003
   PubMed Web of Science ®Google Scholar
• Ward IM, Difilippantonio S, Minn K, Mueller MD, Molina JR, Yu X, et al. 53BP1 cooperates with p53 and functions as a haploinsufficient tumor suppressor in mice. Mol Cell Biol. 2005;25:10079–10086. doi:10.1128/MCB.25.22.10079-10086.2005
   PubMed Web of Science ®Google Scholar
• Gassmann R, Carvalho A, Henzing AJ, Ruchaud S, Hudson DF, Honda R, et al. Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J Cell Biol. 2004;166:179–191. doi:10.1083/jcb.200404001
   PubMed Web of Science ®Google Scholar
• Takami T, Terai S, Yokoyama Y, Tanimoto H, Tajima K, Uchida K, et al. Human homologue of maid is a useful marker protein in hepatocarcinogenesis. Gastroenterology 2005;128:1369–1380. doi:10.1053/j.gastro.2005.03.014
   PubMed Web of Science ®Google Scholar
• Ma W, Stafford LJ, Li D, Luo J, Li X, Ning G, et al. GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis. J Cell Biochem. 2007;100:1376–1386. doi:10.1002/jcb.21140
   PubMed Web of Science ®Google Scholar
• Ma W, Xia X, Stafford LJ, Yu C, Wang F, LeSage G, et al. Expression of GCIP in transgenic mice decreases susceptibility to chemical hepatocarcinogenesis. Oncogene. 2006;25:4207–4216. doi:10.1038/sj.onc.1209450
   PubMed Web of Science ®Google Scholar
• Sonnenberg-Riethmacher E, Wüstefeld T, Miehe M, Trautwein C, Riethmacher D. Maid (GCIP) is involved in cell cycle control of hepatocytes. Hepatology. 2007;45:404–411. doi:10.1002/hep.21461
   PubMed Web of Science ®Google Scholar
• Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998;20:189–193. doi:10.1038/2496
   PubMed Web of Science ®Google Scholar
• Zhu J, Abbruzzese JL, Izzo J Hittelman WN, Li D. AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells. Cancer Genet Cytogenet. 2005;159:10–17. doi:10.1016/j.cancergencyto.2004.09.008
   PubMedGoogle Scholar
• Humbert N, Navaratnam N, Augert A, et al. Regulation of ploidy and senescence by the AMPK-related kinase NUAK1. EMBO J. 2010; 29:376–386. doi:10.1038/emboj.2009.342
   PubMed Web of Science ®Google Scholar
• Lentini L, Barra V, Schillaci T, et al. MAD2 depletion triggers premature cellular senescence in human primary fibroblasts by activating a p53 pathway preventing aneuploid cells propagation. J Cell Physiol. 2012;227:3324–3332. doi:10.1002/jcp.24030
   PubMed Web of Science ®Google Scholar
• Meena JK, Cerutti A, Beichler C, et al. Telomerase abrogates aneuploidy-induced telomere replication stress, senescence and cell depletion. EMBO J. 2015;34:1371–1384. doi:10.15252/embj.201490070
   PubMed Web of Science ®Google Scholar